Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
London Stock Exchange: HIK | OTC Bulletin Board: HKMPF | OTC Bulletin Board: HKMPY
Hikma Pharmaceuticals Plc develops, manufactures and markets both branded and non-branded generic and in-licensed products. Hikma operates in three business segments: Branded, Injectables and Generics in the Middle East and North Africa. The Branded segment focuses on the MENA region. It develops, manufactures, and markets branded generics and a portfolio of in-licensed products, many of which are still patent protected. The Generics segment entirely focuses on the U.S. market for oral generics. The Injectables segment manufactures generic injectables. The company was founded by Samih Darwazah in 1978 and is headquartered in London, the United Kingdom.
Solna, SE
BillerudKorsnäs offers primary fibre-based packaging material and packaging solutions. The company has a prominent position within… Learn more →

Glasgow, SC, GB
Devro Plc manufactures collagen and plastic products for the food industry. It sells collagen casings under the three brands Devrotm,… Learn more →

San Diego, CA, US
Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company is leveraging… Learn more →

London, LO, GB
Johnson Matthey Plc produces catalysts, precious metals and specialty chemicals. The operations of the company are organized into… Learn more →